FCMI

Foresite Capital Management IV Portfolio holdings

AUM $230M
1-Year Est. Return 64.1%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+64.1%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$288M
AUM Growth
+$66.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
18
New
Increased
Reduced
Closed

Top Buys

1
+$14.3M
2
+$10M
3
+$8.41M
4
ABUS icon
Arbutus Biopharma
ABUS
+$6.94M
5
EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
+$5.14M

Top Sells

1
+$17.6M
2
+$13.5M
3
+$5.57M
4
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
+$2.39M
5
CBAY
Cymabay Therapeutics
CBAY
+$1.11M

Sector Composition

1 Healthcare 89.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$42.6M 14.79%
1,800,587
+1,362
2
$33.6M 11.69%
851,200
3
$29.2M 10.13%
1,231,543
+158,271
4
$28.1M 9.76%
565,755
+173,800
5
$27.2M 9.43%
2,023,369
-88,500
6
$26M 9.03%
61,903
+29,663
7
$22.6M 7.84%
721,903
+521,903
8
$19.4M 6.73%
2,651,825
+1,166,580
9
$18M 6.25%
270,424
-204,995
10
$17.9M 6.21%
1,130,919
+300,000
11
$10.6M 3.67%
529,551
+100,000
12
$4.99M 1.73%
+245,082
13
$3.61M 1.25%
295,000
-355,000
14
$2.24M 0.78%
+75,000
15
$1.64M 0.57%
+94,477
16
$403K 0.14%
10,650
-549,423
17
– –
-9,355
18
– –
-450,000